- Home
- VS vs BOLT Comparison
VS vs BOLT Comparison
Compare VS & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VS
- BOLT
- Stock Information
- Founded
- VS 2013
- BOLT 2015
- Country
- VS United States
- BOLT United States
- Employees
- VS N/A
- BOLT N/A
- Industry
- VS EDP Services
- BOLT Biotechnology: Pharmaceutical Preparations
- Sector
- VS Technology
- BOLT Health Care
- Exchange
- VS Nasdaq
- BOLT Nasdaq
- Market Cap
- VS 9.6M
- BOLT 9.4M
- IPO Year
- VS N/A
- BOLT 2021
- Fundamental
- Price
- VS $2.08
- BOLT $5.18
- Analyst Decision
- VS Hold
- BOLT Buy
- Analyst Count
- VS 1
- BOLT 3
- Target Price
- VS $2.00
- BOLT $47.50
- AVG Volume (30 Days)
- VS 315.5K
- BOLT 12.8K
- Earning Date
- VS 11-13-2025
- BOLT 11-11-2025
- Dividend Yield
- VS N/A
- BOLT N/A
- EPS Growth
- VS N/A
- BOLT N/A
- EPS
- VS N/A
- BOLT N/A
- Revenue
- VS $2,183,196.00
- BOLT $4,167,000.00
- Revenue This Year
- VS $3,459.21
- BOLT N/A
- Revenue Next Year
- VS N/A
- BOLT N/A
- P/E Ratio
- VS N/A
- BOLT N/A
- Revenue Growth
- VS 1873.85
- BOLT N/A
- 52 Week Low
- VS $1.00
- BOLT $4.59
- 52 Week High
- VS $9.59
- BOLT $14.36
- Technical
- Relative Strength Index (RSI)
- VS 49.67
- BOLT 47.14
- Support Level
- VS $1.80
- BOLT $5.00
- Resistance Level
- VS $2.02
- BOLT $5.50
- Average True Range (ATR)
- VS 0.09
- BOLT 0.23
- MACD
- VS 0.03
- BOLT 0.04
- Stochastic Oscillator
- VS 96.55
- BOLT 53.69
About VS Versus Systems Inc.
Versus Systems Inc offers a suite of proprietary business-to-business software tools that are meant to drive user engagement through gamification and rewards. These tools allow its partners to offer in-game prizes and rewards, including merchandise, coupons, digital goods, and sweepstakes entries - inside their websites, their venues, or their streaming media content. Its customers are mostly sports teams, venues, and advertising agencies, which typically use its products as part of their live events or as part of an advertising campaign with the goal of engaging fans, increasing consented first-party data, and increasing sales. The company operates in Canada and the USA.
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.